Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-03 Sale | 2024-04-04 4:14 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 72,995 | $9.4577 | $690,365 | 678,457 (Direct) | View |
| 2022-01-03 Sale | 2022-01-04 9:31 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 4,500 | $64.71 | $291,177 | 17,000 (Direct) | View |
| 2021-12-01 Purchase | 2021-12-02 5:12 pm | Kronos Bio Inc. | KRON | De Backer Marianne Director | 1,150 | $11.57 | $13,306 | 2,750 (Direct) | View |
| 2021-08-20 Purchase | 2021-08-24 7:24 pm | Kronos Bio Inc. | KRON | De Backer Marianne Director | 1,000 | $19.57 | $19,565 | 1,600 (Direct) | View |
| 2021-06-24 Sale | 2021-06-25 6:59 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 5,000 | $89.85 | $449,250 | 21,500 (Direct) | View |
| 2021-05-28 Purchase | 2021-06-01 4:08 pm | Kronos Bio Inc. | KRON | De Backer Marianne Director | 600 | $25.01 | $15,006 | 600 (Direct) | View |
| 2020-10-08 Purchase | 2020-10-26 6:02 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 1,000 | $50.47 | $50,465 | 17,500 (Direct) | View |
| 2020-01-13 Purchase | 2020-06-24 6:10 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 4,000 | $33.56 | $134,240 | 16,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-22 Option Award | 2024-02-26 7:32 pm | N/A 2034-02-21 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 525,000 | $0 | 1,101,452 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:11 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | De Backer Marianne Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-04 4:53 pm | N/A 2033-04-02 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 1,729,356 | $0 | 1,729,356 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:38 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 12,460 | $0 | 35,860 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-29 4:14 pm | N/A 2032-06-21 | Kronos Bio Inc. | KRON | De Backer Marianne Director | 28,333 | $0 | 31,083 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 8:07 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 6,400 | $0 | 23,400 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 9:21 pm | N/A 2031-06-21 | Kronos Bio Inc. | KRON | De Backer Marianne Director | 8,583 | $0 | 8,583 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 5:03 pm | N/A N/A | Kronos Bio Inc. | KRON | De Backer Marianne Director | 41,200 | $0 | 41,200 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-05 6:22 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 9,000 | $0 | 26,500 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 6:10 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 7,500 | $0 | 12,500 (Direct) | View |
Ownership | 2019-12-27 4:51 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 0 | $0 | 5,000 (Direct) | View |